Sub-Saharan Africa faces region-specific risk factors for Background chronic kidney disease (CKD), such as nephrotoxic herbal medicines, antiretroviral therapy and infections, in addition to hypertension and diabetes. However, large epidemiological studies from this area are scarce.
Abstract
: Sub-Saharan Africa faces region-specific risk factors for Background chronic kidney disease (CKD), such as nephrotoxic herbal medicines, antiretroviral therapy and infections, in addition to hypertension and diabetes. However, large epidemiological studies from this area are scarce.
: In a cross-sectional survey of non-communicable diseases, we Methods conducted a prevalence sub-study of CKD in two Malawian populations. Study participants (N=5264) of 18 years of age and above were recruited and data on demographics and CKD risk factors were collected. Glomerular filtration rate was estimated (eGFR) using the CKD-EPI equation.
: The prevalence of eGFR<60ml/min/1.73m was 1.4% (95% CI 1.1 Results -1.7%) and eGFR<90ml/min/1.73m was 20.6% (95% CI 19.5 -21.7%). The rural area had higher age-standardized prevalence of both eGFR<60ml/min/1.73m , at 1.8% (95% CI 1.4 -2.3) and eGFR <90 ml/min/1.73m², at 21.1% (95% CI 19.9 -22.3), than urban location, which had a prevalence of 1.5%, (95% CI 1.0 -2.2) and 19.4% (95% CI 18.0 -20.8), respectively, with overlapping confidence intervals. The prevalence of CKD was lower in females than in males in both rural and urban areas. Older age (p < 0.001), a higher level of education (p = 0.03) and hypertension (p < 0.001) were associated with a higher adjusted odds ratio (aOR) of low eGFR. Diabetes was associated with a reduced aOR of eGFR<90ml/min/1.73m of 0.69 (95% CI 0.49-0.96; p=0.03). Of participants with eGFR<60ml/min/ 1.73m , 14 (19.4%) had no history of hypertension, diabetes or HIV, while 36 (50%) had a single risk factor of being hypertensive.
: Impaired renal function is prevalent, but lower than Conclusions expected, in rural and urban Malawi. Further research is needed to increase
Introduction
Since 1990, the number of deaths from chronic kidney disease (CKD) has risen by 82%, representing the third largest increase in deaths, behind HIV/AIDS and diabetes 1, 2 . CKD, described as abnormalities of kidney structure or function present for longer than three months, is increasingly being recognized as an emerging public health problem globally and a key determinant of poor health outcomes of millions of people 3-5 . Sub-Saharan Africa (sSA) faces region-specific risk factors for CKD, such as nephrotoxic herbal medicines, antiretroviral therapy and infections, in addition to hypertension and diabetes 6, 7 . The few epidemiological studies in sSA show a large variation of CKD prevalence, ranging from 1.5% to 33.5% 8 .
However, current knowledge about the prevalence of CKD and renal disease in Malawi, as in most sSA countries, is scarce 9 . Published data on CKD have been based on opportunistic sampling, involving people seeking medical care, or of urban populations, who have a different epidemiological profile from the rural majority 6, 10 . It is thought that glomerulonephritis and CKD of unknown origin (CKDu), might account for a larger proportion of the total CKD burden in rural or disadvantaged populations, whilst hypertension and diabetes are more prevalent in urban areas 3, 11 .
The absence of community-based representative data on CKD is concerning, as strategies aimed at managing CKD in Africa critically depend on reliable assessment of the burden of the problem and the establishment of affordable early detection programs 12 . As such, we conducted a cross-sectional survey to estimate and compare the prevalence of CKD in rural and urban Malawi and analyzed the factors associated with this condition.
Methods

Study setting
Participants were selected from a large cross-sectional population-based survey, designed to elucidate the burden and risk factors of non-communicable diseases in urban and rural Malawi 13,14 . The survey was conducted in a rural area with a population of 40,000 people within southern Karonga District and Area 25 in Lilongwe, the capital city ( Figure 1 ). Karonga is a lakeshore district, with a subsistence economy. Area 25 is an economically mixed urban economy with a population of around 66,000 individuals. Recruitment and data collection took place between May 16 th 2013 to February 8 th 2016.
Recruitment and data collection
Detailed study procedures of the survey and characteristics of the two populations have been previously described 13 and all consenting adults age 18 years and over, residing within the defined study areas, were eligible to participate.
Briefly, the participants were visited in their homes. Written informed consent was obtained from all participants for interviewer-led questionnaires, documenting the participant's socio-demographic information, lifestyle (e.g. smoking, alcohol, diet and physical activity), personal and family health history (e.g. hypertension, diabetes, heart disease and HIV) and current medications. Anthropometric measurements, measured twice by two study staff independently, and three seated blood pressure measurements, with 5 minute rests in between, were taken, adhering to standard protocols. A rapid HIV test was conducted, and results were given to the participants.
Blood was collected from an antecubital vein (following an overnight fast of at least 8h) in sodium fluoride tubes and plain serum tubes for fasting blood glucose (FBG) and serum creatinine tests, respectively. The samples were transported on the same day to the onsite project laboratory for the glucose assay and the serum was stored for creatinine analysis (mean time between collection and processing of 2.6h). We used the hexokinase glucose-6-phosphate dehydrogenase method using the AU480 Chemistry Analyzer (Beckman Coulter, California, USA), with sufficient sensitivity (range 0.555-44.4 mol/L) to determine glucose concentrations in the study samples.
Serum separation was done on a Sigma 6-16 centrifuge at 3000 RPM for 10 minutes. The separated serum was frozen in -80 freezer in 1.8ml Sarstedt tubes. On the day of analysis, the serum samples were taken out of the freezer, allowed to thaw at room temperature and then analysed on an AU480 analyser with ISE. Kinetic Jaffe (compensated) method, traceable to the isotope dilution mass spectrometry (IDMS) reference method was used. The AU480 analyser automatically computed the creatinine concentration of each sample and interference from protein was mathematically auto-corrected by the analyser by subtracting 18 μmol/L from each test result. The instrument was equipped with reagent OSR6178, System Calibrator Cat. No. 66300 traceable to the IDMS method via National Institute of Participant ages were grouped into 10-year categories and education was categorized by the highest educational level achieved (no formal education, completed primary school standard 1-5, primary school standard 6-8, secondary, or tertiary). Occupation statuses were grouped into the following categories: not working, housework, farming or fishing, employed or self-employed. Household wealth scores were determined, based on the value of household assets, and then grouped into fifths across the total survey population. Physical activity was determined by self-reporting of the average duration (minutes) and intensity of exercise (pre-coded activities, grouped into high exertion, low exertion, or sedentary) in the previous week (both at work and during leisure time), used to establish whether participants met the World Health Organization (WHO) recommended level of activity per week. Alcohol consumption was divided into those who had consumed at least one alcoholic drink within the past 12 months and those who had not. Smoking status was divided into current smokers, ex-smokers and never-smokers.
Body mass index (BMI) categories were <18kg/m 2 (underweight), 18-24.99 kg/m 2 (healthy weight), 25-29.99 kg/m 2 (overweight) and >30 kg/m 2 (obese), in line with World Health Organization recommendations. Hypertension was defined as one or more of: systolic blood pressure of 140mmHg or more; diastolic blood pressure of 90 mmHg or more; and any use of antihypertensive medication in the past two weeks. Diabetes was defined as fasting plasma glucose of at least 7.0 mmol/L or any self-reported prior diagnosis of diabetes, regardless of whether the participant was taking anti-diabetic medication.
Sampling participants for serum creatinine measurements
Serum samples were available for 24,780 participants; we sampled 5,264 serum samples for creatinine testing. With this sample size, we were able to determine a 0.1 standard difference, with power of 80% and p value of 0.01. Our sample was stratified by age (18-29, 30-39, 40-49, 50+) , sex and site. We over-sampled older (aged 40 years plus) age groups in order to increase the numbers of individuals with impaired renal function to facilitate further analyses and prioritized participants recruited later in the study over those recruited earlier. Specifically, we tested 100 of each age/sex/site combination group for both 2015 and 2014, the remaining samples coming from participants aged 40 and older from 2015.
Method of calculating of eGFR
We used the CKD-EPI equation to calculate eGFR:
Where S Cr is serum creatinine in μmol/L; K is 61.9 for females and 79.6 for males; α is -0.329 for females and -0.411 for males; Min indicates the minimum of S Cr /K or 1, and max indicates the maximum of S Cr /L or 1.
Using the this equation, not correcting for race, renal function was categorized as: eGFR <60 ml/min/1.73 m 2 (very low eGFR, representing CKD), <90 ml/min/1.73 m 2 (low GFR) and ≥90 ml/min/1.73 m 2 (normal), based on the National Kidney Foundation guidelines.
Statistical analyses
We calculated the age-specific prevalence of eGFR<60ml/ min/1.73m 2 and eGFR<90ml/min/1.73m 2 according to rural or urban residency and sex and estimated population prevalence, weighted to represent the age distribution of the underlying study population, using age groups of 18-29, 30-39, 40-49, and 50+, in line with the strategy used for sampling for the creatinine assay. In addition, the age-standardized prevalence (to the INDEPTH Standard population distribution 2000 -2005 15 ) was estimated.
We conducted multivariable logistic regression to examine the association of different exposures with having an eGFR<90ml/min/1.73m 2 . Exposures were considered in a conceptual framework of distal exposures (age, sex, urban or rural study site, education, occupation and household wealth score), behavioral exposures (smoking, alcohol consumption and physical activity) and pathological exposures (obesity, hypertension and impaired fasting glucose), displayed in Figure 2 . We report the odds ratios (ORs) with 95% confidence intervals (CIs) for each of these exposures, adjusted for age and sex only, for distal exposures only, and for both distal and behavioral exposures. Complete case analysis was used as a strategy to deal with missing data. All analysis was done using Stata version 15.0 (StataCorp, College Station, TX).
Ethical statement
All participants gave written consent to participate. Ethical approval was obtained from Malawi National Health Sciences Research Committee protocol number #1072, and London School of Hygiene and Tropical Medicine (UK) Ethics Committee protocol number #6303.
Results
Participant demographic characteristics
The creatinine assay was conducted on serum from 5264 participants. BMI was missing for 123 participants, mainly as it was not calculated in pregnant women. Blood pressure and diabetes data were missing for 3 and 2 participants, respectively. HIV status was not available for 1382 participants.
Socio-demographic characteristics of the participants are described in Table 1 . 55.2% were from the rural area, 27.6% were between age 18 to 29, and 43.4% were farmers or fishermen. The rural sample was generally poorer, less well educated, and most participants were farmers or fishermen. The urban sample comprised more overweight or obese participants and had a higher prevalence of hypertension and diabetes.
Crude and age-specific prevalence The prevalence of eGFR<60ml/min/1.73m 2 in our sample overall was 1.4% (95% CI 1.1 -1.7) and the prevalence of eGFR<90ml/min/1.73m 2 was 20.6% (95% CI 19.5 -21.7). This is shown by age and urban or rural location in Table 2 and Table 3 and Figure 3 and Figure 4 . The rural area had higher prevalence of both eGFR<60ml/min/1.73m 2 , at 1.8% (95% CI 1.4 -2.3), and eGFR<90ml/min/1.73m 2 , at 21.1% (95% CI 19.9 -22.3), than the urban location, which had a prevalence of 1.5% (95% CI 1.0 -2.2) and 19.4% (95% CI 18.0 -20.8), respectively, although with overlapping confidence intervals when standardized to the INDEPTH standard age distribution. The prevalence of eGFR<60ml/min/1.73m 2 was also slightly lower in females than in males in both rural and urban areas.
Exposures associated with low eGFR
Low eGFR was strongly associated with increasing age ( (95% CI 90.88 -242.27). Other exposures associated with low eGFR in the fully-adjusted model were having a higher education level (p=0.03), being a farmer or fisherman, and hypertension (p<0.001). Being underweight was associated with reduced odds of low eGFR (p=0.03). In our sample, diabetes was associated with a reduced adjusted odds ratio (aOR) of eGFR<90ml/min/ 1.73m 2 , with an aOR of 0.57 (95% CI 0.40 -0.81; p=0.001), adjusting for distal and behavioral exposures. Place of residence was associated with eGFR<90ml/min/1.73m 2 with an age-and sex-adjusted OR of 0.84 (95% CI 0.72 -0.98; p=0.03) 3. Missing data on 123 participants 4. Defined as blood pressure ≥140/90 or on antihypertensive medication, missing data on 3 participants 5. Defined as fasting plasma glucose≥7.1 or self-report, missing data on 3 participants BMI, body mass index; OR, odds ratio; CI, confidence intervals for urban residence, with rural as the reference. The association was no longer seen when also adjusting for distal or behavioral exposures.
Of those who had eGFR<60ml/min/1.73m 2 , 14 (19.4%) had no history of hypertension, diabetes or HIV (Table 5 ). Thirty-six (50.0%) of the participants with eGFR<60ml/min/1.73m 2 had a single risk factor of being hypertensive, eight (11.1%) had a single risk factor of HIV and nine (19.4%) had two known risk factors of CKD.
Discussion
In this large, population-based, cross-sectional stratified sample, we found an overall standardized prevalence of eGFR<90ml/ min/1.73m 2 of 20.6% and eGFR<60ml/min/1.73m 2 of 1.4% using the CKD-EPI equation. A study conducted in Lilongwe by Glaser et al. found a prevalence of eGFR<60ml/min/1.73m 2 of 3.1%, in individuals seeking HIV testing in urban Malawi 8 . These estimates are comparable to those found in other regional studies and validate a growing body of research indicating presence of undiagnosed CKD at population level 16, 17 .
In our study, low eGFR was associated with occupation (farmers/ fisherman more likely to have decreased eGFR), increasing age, and hypertension and was inversely associated with being underweight in fully adjusted analyses. These associations are similar to those found by Kalyesubula et al. in rural Uganda 17 . The high prevalence of CKD amongst rural participants and farmers has been documented in other literature 18 . Rural agricultural communities from Central America, Egypt, India, and Sri Lanka have reported a high prevalence of CKDu of unknown etiology, and a clinical presentation suggestive of interstitial nephritis, confirmed by renal biopsies, with male farm workers affected disproportionately 3 . The rural site investigated in the study has a high population of males working in agricultural fields in similar circumstances to those studied in other regions and we could postulate that it has similar epidemiology, but more research is required. Alternately, the result could be confounded by higher creatinine levels due to the high muscle mass in this physically active group. Similarly, the lower odds of CKD in underweight participants may reflect reduced muscle bulk with lower creatinine production. As expected, loss of renal function in our study was associated with an older age. CKD may be a consequence of expected age-related renal function decline, accelerated in hypertension, diabetes, obesity, and primary renal disorders 5 . Similar studies in other settings have shown that an age of over 60, female gender, low educational status, increased waist circumference, hypertension, and diabetes were associated with low eGFR 16 . The high prevalence of CKD amongst hypertensive participants is in keeping with several similar studies carried out in sSA 1, 6 . Inadequate blood pressure control may explain the prevalence of CKD observed 7 ; however, poor renal function may also lead to an increase in blood pressure.
Our study also suggests an inverse association between renal impairment and diabetes. A survivor bias in the cross-sectional design may explain this association 16 , as it is possible that people with diabetes die before developing renal impairment, or that people with diabetes who develop renal impairment have very poor survival. Additionally, hyperfiltration is a feature of early diabetic nephropathy, associated with a high eGFR. Early diabetic kidney disease would not be picked up from the eGFR alone, and may bias the results in the direction of diabetes being protective for kidney disease 19 .
The results of the study are useful because of the large sample size, the study of the general population rather than patients in a clinical setting, and the ability to compare between rural and urban populations. The previous study conducted in Lilongwe recruited participants attending a HIV Testing and Counselling Centre and may not be a good estimate of population prevalence. In particular, the prevalence of HIV in the study was greater than in the general population and the HIV-negative patients may have been symptomatic for other conditions, prompting self-referral for HIV testing 9 . As our study population is of a similar age and sex structure to the Malawian population and represent typical rural and urban populations, our results are likely to be representative of the rest of the country, and possibly to other similar populations in low resource and low income countries 1 .
A limitation of our study was relying on serum creatinine for the measurement of CKD with no urine albumin:creatinine ratio, since classification of CKD stages one and two includes other evidence of renal damage including proteinuria, haematuria, or evidence of abnormal anatomy or systemic disease. Furthermore, CKD can only be formally diagnosed if low eGFR and/or a high urine albumin:creatinine ratio have been found at two different times, with at least a three month gap 2 , and 30-40% of patients labelled as CKD stage 3A when the diagnosis is based on only a single eGFR determination move to 'normal' 2 . Therefore, the reported prevalence of CKD might be overestimated 7 . However, as nearly all other prevalence studies have defined CKD based on a one-off measurement of eGFR <60 mL/min/1.73m 2 , this does allow our results to be directly comparable to much of the published data 2,20 . Furthermore, the study used CKD-EPI 1 Participants with missing data on any of the three risk factors examined were classified as not having known risk factor equation in the determination of eGFR, which is considered to be a more accurate predictor of clinical risk than other serumbased equations, including the Modification of Diet in Renal Disease (MDRD) equation 5 . However, the CKD-EPI equation has not been validated for the African population, so it is possible that calculated eGFR is not reflecting the underlying kidney function accurately in our population. Finally, cross-sectional studies do not allow one to derive a causal inference, which is particularly important when considering the relationship between hypertension, diabetes and CKD.
Conclusion
Our study is the first to estimate population-level prevalence of CKD in urban and rural Malawi, and highlights that there is already a substantial burden of disease. With an ageing population and increasing prevalence of hypertension, this is likely to increase over the coming decades. Furthermore, in the absence of screening of high-risk individuals, diagnosis, and appropriate service provision, poor survival with CKD is likely and this estimated prevalence may mask a much higher incidence.
Longitudinal research is urgently needed to increase understanding of CKD incidence, survival and validation of eGFR calculations in this population.
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However, though the authors examined the population for the presence of hypertension and diabetes mellitus I did not see any data on the duration of the diabetes and hypertension and even the therapy these patients or participants used. I think this is relevant since earlier studies have established a relationship between duration of these chronic conditions and CKD as well as the medications and CKD Secondly the study of Ephraim and also Janmohammed estimated or identified evidence of et al et al kidney damage by measuring microalbuminuria or dipstick proteinuria I realized that the authors did not mention anything on evidence of renal damage. Authors should provide reasons for this omission.
CKD diagnosis is either based on the KDIGO or KDOQI guidelines Which of these did the authors use and why? 123 participants included in this analysis were pregnant. BMI was not calculated for these participants. Pregnancy is known to be related to eGFR (the outcome variable) and several of the exposure variables such as blood pressure. Could this be a hidden confounder in your analysis? What was the association between pregnancy and eGFR?
In Table 2 , some of the superscripts listed in the footnote are not clearly visible within the table.
Conclusions
If I am interpreting Table 5 correctly, 58/72 of the participants with eGFR < 60 had HTN. This point should be emphasized in the discussion and the implications for linking HTN and kidney disease screening should be discussed.
Are the fisherman/farmers exposed to schistosomiasis? Could this or some other helminthic infection explain the link between fisherman/farmers and CKD? This possibility should be discussed and references should be listed.
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